Literature DB >> 23878714

The Expression of Interleukin-1b and miRNA-146a in the Cerebral Cortex of Acute Escherichia Coli Meningitis Immature Rat Model.

Ahmed Omran1, Jing Peng, Ciliu Zheng, Jinfeng Xue, Qiu-Lian Xiang, Fei Yin.   

Abstract

The main limitation to advances in treatment of bacterial meningitis and its complications is the incomplete knowledge of the pathogenesis and pathophysiology of this disease. The aim of this research is to detect the expression of interleukin (IL)-1β as pro-inflammatory cytokine and miRNA (miR)-146a as post transcriptional inflammation associated microRNA (miRNA) in the cerebral cortex of acute Escherichia coli (E. coli) meningitis immature rat model. Immature rats in the post natal day 11 (PN11) were used to construct a model of acute E. coli meningitis and served as controls. The expression of IL-1β and miR-146a were detected in the cerebral cortex by reverse transcription polymerase chain reaction (RT-PCR) and real-time quantitative PCR (qPCR) analysis respectively, 24 hours after bacterial inoculation. In the cerebral cortical tissue of acute E. coli meningitis immature rat model the IL-1β expression was significantly upregulated while the miR-146a expression was significantly downregulated. This study tried to add a new insight on the molecular basis of the E. coli meningitis pathogenesis at its very early stage through detecting the expression of IL-1β and miR-146a in the cerebral cortex of the infected immature rats. Consequently, modulation of the IL-1β- miR-146a axis may be a new target for treatment of acute E. coli meningitis.

Entities:  

Keywords:  E coli meningitis; IL-1β; Pathogenesis; immature rat; miR-146a

Year:  2012        PMID: 23878714      PMCID: PMC3578646          DOI: 10.4314/ajid.v6i2.3

Source DB:  PubMed          Journal:  Afr J Infect Dis        ISSN: 2006-0165


  30 in total

1.  A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience.

Authors:  I M Gladstone; R A Ehrenkranz; S C Edberg; R S Baltimore
Journal:  Pediatr Infect Dis J       Date:  1990-11       Impact factor: 2.129

Review 2.  Pathogenesis and pathophysiology of bacterial CNS infections.

Authors:  Johann Sellner; Martin G Täuber; Stephen L Leib
Journal:  Handb Clin Neurol       Date:  2010-01-19

Review 3.  MicroRNA-146a and human disease.

Authors:  L Li; X-P Chen; Y-J Li
Journal:  Scand J Immunol       Date:  2010-04       Impact factor: 3.487

4.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

5.  Inhibition of Escherichia coli-induced meningitis by carboxyfullerence.

Authors:  N Tsao; P P Kanakamma; T Y Luh; C K Chou; H Y Lei
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

6.  An extensive class of small RNAs in Caenorhabditis elegans.

Authors:  R C Lee; V Ambros
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

Review 7.  Rat model of perinatal hypoxic-ischemic brain damage.

Authors:  R C Vannucci; J R Connor; D T Mauger; C Palmer; M B Smith; J Towfighi; S J Vannucci
Journal:  J Neurosci Res       Date:  1999-01-15       Impact factor: 4.164

8.  Identification of Escherichia coli outer membrane protein A receptor on human brain microvascular endothelial cells.

Authors:  Nemani V Prasadarao
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

9.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.

Authors:  Yuanjia Tang; Xiaobing Luo; Huijuan Cui; Xuming Ni; Min Yuan; Yanzhi Guo; Xinfang Huang; Haibo Zhou; Niek de Vries; Paul Peter Tak; Shunle Chen; Nan Shen
Journal:  Arthritis Rheum       Date:  2009-04

10.  Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation.

Authors:  O Ramilo; X Sáez-Llorens; J Mertsola; H Jafari; K D Olsen; E J Hansen; M Yoshinaga; S Ohkawara; H Nariuchi; G H McCracken
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

View more
  1 in total

1.  MicroRNAs: a light into the "black box" of neuropediatric diseases?

Authors:  Ahmed Omran; Dalia Elimam; Sherien Shalaby; Jing Peng; Fei Yin
Journal:  Neuromolecular Med       Date:  2012-07-19       Impact factor: 3.843

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.